Skip to Main Content

Author Details

Susan J Done
University Health Network
1994
99
34
PMIDPaper TitleJournal TitlePublished Year
35802936Resident Depression and Burnout During the COVID-19 Pandemic: A Survey of Canadian Laboratory Medicine Trainees.Arch Pathol Lab Med2023
37754535Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women.Curr Oncol2023
34556523Mutations in Noncoding <i>Cis</i>-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer.Mol Cancer Res2022
35068172Annual Mammographic Screening Reduces the Risk of Interval or Higher Stage Invasive Breast Cancers Among Postmenopausal Women in the Ontario Breast Screening Program.Can Assoc Radiol J2022
35242442MiNuGAN: Dual Segmentation of Mitoses and Nuclei Using Conditional GANs on Multi-center Breast H&amp;E Images.J Pathol Inform2022
34253233Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trial.Breast Cancer Res2021
33616312The tumor cell-derived matrix of lobular breast cancer: a new vulnerability.EMBO Mol Med2021
34518219Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer.Proc Natl Acad Sci U S A2021
34711609Heterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response.Cancer Res2021
34475389Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer.Nat Commun2021
34015808A Holistic Approach to Pathology Education During the Coronavirus Disease 2019 (COVID-19) Pandemic.Arch Pathol Lab Med2021
31233138Annual vs Biennial Screening: Diagnostic Accuracy Among Concurrent Cohorts Within the Ontario Breast Screening Program.J Natl Cancer Inst2020
31964786A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer.Clin Cancer Res2020
32062352Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis.EBioMedicine2020
32888139Lobular neoplasia occult on conventional imaging and diagnosed on MRI-guided biopsy: can we estimate upgrade on surgical pathology?Breast Cancer Res Treat2020
32832633Cell invasion in digital microfluidic microgel systems.Sci Adv2020
32396665Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor?J Surg Oncol2020
31233143Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.J Natl Cancer Inst2020
30670564Breast specimen handling and reporting in the post-neoadjuvant setting: challenges and advances.J Clin Pathol2019
28781102Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.Breast2018
29982234Breast tumour resembling tall cell variant of papillary thyroid carcinoma: case presentation (in a patient with Lynch syndrome).J Clin Pathol2018
30415952MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.Mol Cell2018
30332649Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast.Cell Rep2018
28819847Negative Enrichment and Isolation of Circulating Tumor Cells for Whole Genome Amplification.Methods Mol Biol2017
29093438Mapping genomic and transcriptomic alterations spatially in epithelial cells adjacent to human breast carcinoma.Nat Commun2017
28560673Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures.Adv Exp Med Biol2017
27867715Changes of collagen ultrastructure in breast cancer tissue determined by second-harmonic generation double Stokes-Mueller polarimetric microscopy.Biomed Opt Express2016
26334680Digital Compared with Screen-Film Mammography: Measures of Diagnostic Accuracy among Women Screened in the Ontario Breast Screening Program.Radiology2016
27618023Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation.Int J Mol Sci2016
25527357B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.Cancer Immunol Res2015
26518019Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.Breast Cancer Res Treat2015
26400062Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients.Cancer Res2015
26185737Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysis.Springerplus2015
25849721Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.Breast Cancer Res2015
25964246Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy.J Clin Oncol2015
25682077Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial.Breast Cancer Res Treat2015
25620030Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression.Cancer Cell2015
25459109Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumab.Nucl Med Biol2015
25529931Identification of genomic signatures in circulating tumor cells from breast cancer.Int J Cancer2015
23435421PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling.Oncogene2014
25220719Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.Int J Radiat Oncol Biol Phys2014
24996446Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations.Breast Cancer Res2014
25108740Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.Breast Cancer Res Treat2014
24523627Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis.Curr Oncol2014
23708664Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.Oncogene2014
23064777Incidence of breast cancer in patients with pure flat epithelial atypia diagnosed at core-needle biopsy of the breast.Ann Surg Oncol2013
23674784Digital compared with screen-film mammography: performance measures in concurrent cohorts within an organized breast screening program.Radiology2013
23708085Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis.Int J Radiat Oncol Biol Phys2013
23456231Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.Breast Cancer Res Treat2013
22363530Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival.PLoS One2012
  • 1 - 50 of 99

Recommended Authors

Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 3
Francisco Beca
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Career Start Year 2007
Number of shared co-authors 1
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 3
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Career Start Year 2004
Number of shared co-authors 5
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 3
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 0
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 2
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 2
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 2
Maryou B Lambros
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 2
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 1
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 3
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 0
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 2
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 5
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 1
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 8
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 0
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 2
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 1
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 1
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 7
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 2
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 5
Sunil R Lakhani
University of Queensland
Career Start Year 1983
Number of shared co-authors 2
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 2
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 2

Collaborators

David R McCready
University of Toronto, University Health Network
Co-authored papers 17
Bruce Youngson
University Health Network
Co-authored papers 15
Nona Arneson
Ontario Cancer Institute, Princess Margaret Hospital
Co-authored papers 15
Naomi Miller
Campbell Family Institute for Breast Cancer Research, University Health Network
Co-authored papers 14
Wey L Leong
University Health Network
Co-authored papers 11
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 8
Dong-Yu Wang
College of Pharmaceutical Sciences, Shanghai Jiao Tong University
Co-authored papers 8
Keisha Warren
Co-authored papers 8
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 8
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 8
Irene L Andrulis
University of Toronto
Co-authored papers 7
Juan Moreno
University of Toronto
Co-authored papers 7
Vladimir Iakovlev
St. Michael's Hospital, University of Toronto
Co-authored papers 7
Nisha Kanwar
University of Toronto, the Hospital for Sick Children.
Co-authored papers 6
Andrew J Elia
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 5
Thomas R Cawthorn
Sick Kids Hospital
Co-authored papers 4
Hilmi Ozcelik
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 4
Hal K Berman
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Heiko Blaser
Princess Margaret Cancer Centre
Co-authored papers 3
Andrew Wakeham
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Co-authored papers 3
Arezou A Ghazani
Brigham and Women's Hospital, USA Harvard Medical School
Co-authored papers 3
Eldad Zacksenhaus
University of Toronto
Co-authored papers 3
Chiara Gorrini
Division of Clinical Studies, The Institute of Cancer Research
Co-authored papers 3
Jacqueline M Mason
Campbell Family Institute for Breast Cancer Research, University Health Network
Co-authored papers 3
Paul C Boutros
University of California los angeles
Co-authored papers 3
Alexandra M Easson
University of Toronto
Co-authored papers 3
Ranju Nair
Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital
Co-authored papers 3
Jeremy A Squire
University of Sao Paulo
Co-authored papers 2
John M S Bartlett
University of Edinburgh
Co-authored papers 2
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Release 1.2